Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

VCEL
Vericel Corporation
stock NASDAQ

At Close
Jan 27, 2026 3:59:46 PM EST
36.55USD-3.050%(-1.15)408,327
0.00Bid   0.00Ask   0.00Spread
Pre-market
Jan 27, 2026 9:02:30 AM EST
37.71USD+0.027%(+0.01)5,591
After-hours
Jan 27, 2026 4:00:30 PM EST
36.58USD+0.082%(+0.03)4,709
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 12, 2022
07:30AM EST  Vericel Sees FY21 Revenue Growth 25%-26%   Benzinga
Jan 4, 2022
08:30AM EST  Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 7:30 a.m. Eastern Time.   GlobeNewswire Inc
Dec 21, 2021
07:33AM EST  Truist Securities Maintains Buy on Vericel, Lowers Price Target to $52   Benzinga
Nov 11, 2021
08:30AM EST  Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum on Thursday November 18th, at 10:00a.m. Eastern Time.   GlobeNewswire Inc
Nov 9, 2021
11:42AM EST  The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data   Benzinga
11:42AM EST  Recap: Vericel Q3 Earnings   Benzinga
11:36AM EST  Vericel Q3 EPS $(0.11) Misses $(0.03) Estimate, Sales $34.51M Miss $38.07M Estimate   Benzinga
11:36AM EST  Vericel Sees FY21 Sales $158M-$161M Vs. $169.84M Est.   Benzinga
11:25AM EST  Earnings Scheduled For November 9, 2021   Benzinga
07:40AM EST  Vericel Reports Third Quarter 2021 Financial Results   GlobeNewswire Inc
Nov 8, 2021
08:29AM EST  The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More   Benzinga
Oct 21, 2021
08:30AM EDT  Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the following webcast and conference call to discuss its third-quarter 2021 financial results and business highlights.   GlobeNewswire Inc
Sep 8, 2021
08:30AM EDT  Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on Monday, September 13, 2021, at 4:15p.m. Eastern Time.   GlobeNewswire Inc
Sep 7, 2021
08:30AM EDT  Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, announced the appointment of Patrick J. Fowler as Senior Vice President, Corporate Development and Strategy, effective today.   GlobeNewswire Inc
Aug 5, 2021
06:02AM EDT  SVB Leerink Maintains Outperform on Vericel, Lowers Price Target to $62   Benzinga
Aug 4, 2021
08:13AM EDT  Vericel Sees FY21 Revs $168M-$171M Vs $166.91M Est   Benzinga
08:09AM EDT  Vericel Q2 EPS $(0.08), Inline, Sales $39.52M Beat $36.67M Estimate   Benzinga
08:00AM EDT  Vericel Reports Second Quarter 2021 Financial Results and Raises   GlobeNewswire Inc
07:52AM EDT  The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings   Benzinga
04:10AM EDT  Earnings Scheduled For August 4, 2021   Benzinga
Aug 1, 2021
11:19AM EDT  The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs   Benzinga
Jul 21, 2021
08:30AM EDT  Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the following webcast and conference call to discuss its second-quarter 2021 financial results and business highlights.   GlobeNewswire Inc
Jul 15, 2021
08:15PM EDT  Pomerantz LLP is investigating claims on behalf of investors ofVericel Corporation (Vericel or the Company) (NASDAQ:VCEL). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
Jul 7, 2021
08:30AM EDT  Vericel to Present at the Ladenburg Thalmann Healthcare Conference   GlobeNewswire Inc
Jun 29, 2021
09:23AM EDT  FDA Strikes Off MediWound - Vericel's NexoBrid Biologics License Application; Stocks Drop   Benzinga
08:51AM EDT  Vericel Shares Set To Resume Trade At 9:15 a.m. EDT   Benzinga
08:47AM EDT  Vericel, MediWound Report That FDA Has Determined Application For MexoBrid Cannot Be Approved In Its Present Form   Benzinga
08:45AM EDT  MediWound Receives Complete Response Letter from U.S. FDA for   GlobeNewswire Inc
08:45AM EDT  Vericel Provides Regulatory Update for NexoBrid   GlobeNewswire Inc
08:17AM EDT  The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout   Benzinga
Jun 25, 2021
07:32AM EDT  The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs   Benzinga
Jun 24, 2021
08:12AM EDT  The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO   Benzinga
Jun 9, 2021
09:00AM EDT  Vericel to Present at the Goldman Sachs 42nd Annual Global   GlobeNewswire Inc
Jun 2, 2021
10:38AM EDT  Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates   Benzinga
08:47AM EDT  Vericel Appoints Lisa Wright To Board   RTTNews
08:38AM EDT  Vericel Names Lisa Wright To Board   RTTNews
08:30AM EDT  Vericel Announces Appointment of Lisa Wright to Board of Directors   GlobeNewswire Inc
Jun 1, 2021
05:31PM EDT  Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates   Benzinga
May 13, 2021
08:30AM EDT  Vericel to Present at the Canaccord Genuity Virtual   GlobeNewswire Inc
May 6, 2021
07:34AM EDT  HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $65   Benzinga
May 5, 2021
07:43AM EDT  The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues   Benzinga
07:31AM EDT  Recap: Vericel Q1 Earnings   Benzinga
07:10AM EDT  Vericel Raises FY21 Guidance From $161M-$164M To $165-$168 vs $162.53M Est.   Benzinga
07:09AM EDT  Vericel Q1 Adj. EPS $(0.07) Misses $(0.04) Estimate, Sales $34.60M Beat $32.05M Estimate   Benzinga
07:00AM EDT  Vericel Reports First Quarter 2021 Financial Results and Raises   GlobeNewswire Inc
04:16AM EDT  Earnings Scheduled For May 5, 2021   Benzinga
Apr 28, 2021
07:26AM EDT  The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping   Benzinga
Apr 27, 2021
07:41AM EDT  The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout   Benzinga
Apr 21, 2021
08:37AM EDT  Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the following webcast and conference call to discuss its first-quarter 2021 financial results and business highlights.   GlobeNewswire Inc
Apr 20, 2021
08:07AM EDT  The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex   Benzinga
Apr 9, 2021
09:25AM EDT  Vericel to Present at the 20th Annual Needham Virtual Healthcare   GlobeNewswire Inc
Mar 19, 2021
07:46AM EDT  The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOs   Benzinga
Mar 17, 2021
06:02PM EDT  Vericel Set to Join S&P SmallCap 600 Replacing QEP Resources   Benzinga
06:00PM EDT  Vericel Set to Join S&P SmallCap 600   PR Newswire
Mar 10, 2021
08:30AM EST  Vericel to Present at the Oppenheimer 31st Annual Healthcare   GlobeNewswire Inc
Mar 2, 2021
08:30AM EST  Vericel Announces Webcast of Presentation at Upcoming H.C.   GlobeNewswire Inc
Feb 25, 2021
07:55AM EST  10 Biggest Price Target Changes For Thursday   Benzinga
06:18AM EST  HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $60   Benzinga
05:31AM EST  SVB Leerink Maintains Outperform on Vericel, Raises Price Target to $60   Benzinga
Feb 24, 2021
08:50AM EST  Recap: Vericel Q4 Earnings   Benzinga
08:04AM EST  Vericel Sees FY21 Sales $161M-$164M vs $157.03M Est.   Benzinga
08:03AM EST  Vericel Q4 EPS $0.25 Beats $0.20 Estimate, Sales $45.20M Beat $45.00M Estimate   Benzinga
08:00AM EST  Record Fourth Quarter Total Revenue, Gross Margin, Net Income and Operating Cash Flow   GlobeNewswire Inc
07:30AM EST  The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO   Benzinga
03:35AM EST  Earnings Scheduled For February 24, 2021   Benzinga
Feb 22, 2021
08:30AM EST  Vericel to Present at the SVB Leerink 10th Annual Global   GlobeNewswire Inc
Feb 16, 2021
08:30AM EST  Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, and Joe Mara, CFO, will participate in a fireside chat at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Thursday, February 18, 2021, at 3:00p.m. Eastern Time.   GlobeNewswire Inc
Feb 12, 2021
08:35AM EST  Vericel Announces Termination Of Shareholder Rights Agreement   Benzinga
Feb 11, 2021
11:21AM EST  Stocks That Hit 52-Week Highs On Thursday   Benzinga
Feb 10, 2021
08:00AM EST  Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the following webcast and conference call to discuss its fourth-quarter 2020 financial results and business highlights.   GlobeNewswire Inc
07:34AM EST  The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs   Benzinga
Feb 9, 2021
08:10AM EST  The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement   Benzinga
Feb 5, 2021
07:44AM EST  The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street   Benzinga
Feb 3, 2021
07:31AM EST  The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision   Benzinga
Feb 2, 2021
08:05AM EST  The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment   Benzinga
Jan 27, 2021
07:36AM EST  The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement   Benzinga
Jan 26, 2021
08:07AM EST  The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market   Benzinga
Jan 25, 2021
08:49AM EST  Vericel Appoints Joe Mara As CFO   RTTNews
08:40AM EST  Vericel Announces Appointment Of Joe Mara As CFO   Benzinga
08:30AM EST  Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, announced the appointment of Joe Mara as Chief Financial Officer of the Company, effective today.   GlobeNewswire Inc
Jan 22, 2021
07:22AM EST  The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa   Benzinga
Jan 21, 2021
08:05AM EST  The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping   Benzinga
Jan 20, 2021
07:32AM EST  The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study   Benzinga
Jan 15, 2021
07:57AM EST  The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges   Benzinga
Jan 14, 2021
07:57AM EST  The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates   Benzinga
Jan 13, 2021
07:25AM EST  The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations   Benzinga
Jan 12, 2021
06:14AM EST  HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $44   Benzinga
Jan 11, 2021
12:17PM EST  Oppenheimer Downgrades Vericel to Perform   Benzinga
07:20AM EST  Vericel Sees Prelim. Q4 Sales $44.9M-$45.4M vs $44.73M Est.; Sees Prelim. FY20 Sales $123.9M-$124.4M vs $123.67M Est.   Benzinga
07:15AM EST  Vericel Announces Preliminary Fourth-Quarter and Full-Year 2020   GlobeNewswire Inc
Jan 8, 2021
08:30AM EST  Vericel to Present at the 23rd Annual Needham Growth Conference on   GlobeNewswire Inc
07:25AM EST  The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs   Benzinga
Jan 7, 2021
08:35AM EST  Vericel Announces Expansion of MACI Coverage by UnitedHealthcare to Include Patella and Multiple Cartilage Defects in the Knee   Benzinga
08:30AM EST  Vericel Announces Expansion of MACI Coverage by UnitedHealthcare   GlobeNewswire Inc
Dec 29, 2020
08:09AM EST  The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica   Benzinga
Dec 23, 2020
08:31AM EST  The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut   Benzinga
Dec 22, 2020
07:45AM EST  The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes   Benzinga
Dec 18, 2020
10:10AM EST  Benzinga's Top Upgrades, Downgrades For December 18, 2020   Benzinga
08:30AM EST  Vericel to Present at the 39th Annual J.P. Morgan Healthcare   GlobeNewswire Inc
08:00AM EST  Stephens & Co. Initiates Coverage On Vericel with Overweight Rating, Announces Price Target of $31   Benzinga
Dec 11, 2020
08:11AM EST  The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street   Benzinga
Dec 2, 2020
07:35AM EST  The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod   Benzinga
Nov 17, 2020
08:32AM EST  The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration   Benzinga
Nov 12, 2020
07:44AM EST  The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal   Benzinga
Nov 11, 2020
07:38AM EST  The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap   Benzinga
Nov 10, 2020
08:40AM EST  The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies   Benzinga
Nov 5, 2020
08:04AM EST  Vericel Q3 EPS $0.08 Beats $(0.02) Estimate, Sales $32.30M Beat $31.06M Estimate   Benzinga
07:54AM EST  The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping   Benzinga
04:34AM EST  Earnings Scheduled For November 5, 2020   Benzinga
Nov 2, 2020
08:59AM EST  Morgan Stanley Maintains Equal-Weight on Rocket Companies, Lowers Price Target to $23   Benzinga
08:30AM EST  Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced presentations at the following upcoming investor conferences.   GlobeNewswire Inc
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Oct 22, 2020
08:30AM EDT  Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the following webcast and conference call to discuss its third-quarter 2020 financial results and business highlights.   GlobeNewswire Inc
Oct 19, 2020
12:43PM EDT  BTIG Maintains Buy on Vericel, Raises Price Target to $30   Benzinga
Oct 15, 2020
06:47AM EDT  HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $26   Benzinga
Oct 14, 2020
08:08AM EDT  Vericel Expects Preliminary Total Net Revenues For Q3 To Be $32 Mln   RTTNews
08:07AM EDT  Vericel Sees Q3 Sales ~$32M vs $28.6M Estimate   Benzinga
08:00AM EDT  Double-Digit Revenue, Implant and Biopsy Growth for MACI inthe Quarter and Record Monthly Biopsies in September   GlobeNewswire Inc
Oct 12, 2020
10:35AM EDT  P/E Ratio Insights for Vericel   Benzinga
10:25AM EDT  SVB Leerink Maintains Outperform on Vericel, Raises Price Target to $30   Benzinga
Oct 9, 2020
08:30AM EDT  Vericel To Host Virtual Analyst and Investor Day on October 16, 2020   GlobeNewswire Inc
Sep 17, 2020
02:52PM EDT  Vericel Option Alert: Oct 16 $20 Calls Sweep (17) near the Ask: 301 @ $0.5 vs 190 OI; Earnings 11/3 Before Open [est] Ref=$19.23   Benzinga
05:13AM EDT  Truist Securities Initiates Coverage On Vericel with Buy Rating, Announces Price Target of $24   Benzinga
Sep 16, 2020
07:38AM EDT  Vericel Says FDA Accepts BLA For NexoBrid For The Treatment Of Severe Thermal Burns   RTTNews
07:34AM EDT  Vericel Announces FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal Burns   Benzinga
07:30AM EDT  Vericel Announces FDA Acceptance of Biologics License Application   GlobeNewswire Inc
07:30AM EDT  MediWound Announces FDA Acceptance of Biologics License   GlobeNewswire Inc
Sep 9, 2020
08:30AM EDT  Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced presentations at multiple upcoming investor conferences.   GlobeNewswire Inc
Sep 4, 2020
08:30AM EDT  Vericel to Present at the 18th Annual Morgan Stanley Global   GlobeNewswire Inc
Aug 25, 2020
07:08AM EDT  MediWound And Vericel Announce Acceptance Of First Delivery Of NexoBrid To BARDA For Emergency Response Preparedness   Benzinga
07:00AM EDT  MediWound and Vericel Announce Acceptance of the First Delivery of   GlobeNewswire Inc
Aug 5, 2020
08:44AM EDT  Vericel Q2 EPS $(0.18) Beats $(0.21) Estimate, Sales $20.01M Beat $18.87M Estimate   Benzinga
08:00AM EDT  Product Revenues of $20.0 Million Reported for the Second Quarter   GlobeNewswire Inc
04:21AM EDT  Earnings Scheduled For August 5, 2020   Benzinga
Jul 22, 2020
08:30AM EDT  Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the following webcast and conference call to discuss its second-quarter 2020 financial results and business highlights.   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC